Entering the <$100 genome era, almost everyone will have their DNA sequenced.


With genomes in hand, how do we best predict disease risk and drug targets for each person—so we can best prevent, diagnose, and treat diseases


In our research, we link human genomes to personalized disease risks and treatment targets–often by decoding the molecular, cellular, and functional consequences of disease-driving mutations. We accomplish these goals by developing and applying cutting-edge statistical and machine learning software to diverse, biobank-scale multi-omic datasets. Sounds like fun? Join us!